Stockscreener 앱 받기
1.50
3.23%
-0.05
Actinium Pharmaceuticals Inc 주식(ATNM)의 최신 뉴스
Renaissance Technologies LLC Purchases 63,400 Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
Kirby McInerney LLP Urges Investors in Actinium - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ... - Bluefield Daily Telegraph
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Actinium Pharmaceuticals, Inc.(ATNM) Shareholders - PR Newswire
JPMorgan Chase & Co. Acquires 110,141 Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - GuruFocus
ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for Investors ... - Eagle-Tribune
Class Action Filed Against Actinium Pharmaceuticals, Inc. - GlobeNewswire
Actinium Pharmaceuticals, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationATNM - PR Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
ATNM INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In ATNM To Contact Him Directly To Discuss Their Options - PR Newswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to - Bluefield Daily Telegraph
Lawsuit for Investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) announced by the Shareholders Foundation - Kilgore News Herald
Actinium Pharmaceuticals Inc’s results are impressive - uspostnews.com
Contact The Gross Law Firm by May 27, 2025 Deadline to Join Class Action Against Actinium Pharmaceuticals, Inc.(ATNM) - PR Newswire
The Attractiveness of Investing In Actinium Pharmaceuticals Inc (ATNM) is Growing - knoxdaily.com
Actinium Pharmaceuticals Inc: A Comprehensive Look at the Stock’s Ups and Downs - investchronicle.com
ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
Market Watch Highlights: Actinium Pharmaceuticals Inc (ATNM) Ends on an Downturn Note at 1.30 - DWinneX
ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com
Actinium Pharmaceuticals’ (ATNM) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - PR Newswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, A LEADING NATIONAL FIRM, Encourages Actinium - GlobeNewswire
Actinium Pharma (ATNM) Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models - StreetInsider
Actinium Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models at the American Association for Cancer Research Annual Meeting - Yahoo Finance
Actinium Highlights Mutation Agnostic Antileukemic Activity of Actimab-A Against FLT3, NPM1, KMT2A and TP53 Mutations in AML Models Demonstrating Backbone Potential for Acute Myeloid Leukemia Treatment at the American Association for Cancer Rese - PR Newswire
May 27, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ATNM - PR Newswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - GlobeNewswire
Hematopoietic Stem Cell Transplantation Market to Reach New - openPR.com
ROSEN, A LEADING LAW FIRM, Encourages Actinium - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in - Bluefield Daily Telegraph
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for InvestorsContact Levi & Korsinsky - Morningstar
Investors who lost money on Actinium Pharmaceuticals, Inc. (ATNM) should contact Levi & ... - Bluefield Daily Telegraph
Investors who lost money on Actinium Pharmaceuticals, Inc. - GlobeNewswire
Shareholders that lost money on Actinium Pharmaceuticals, Inc.(ATNM) should contact The Gross Law Firm about pending Class ActionATNM - marketscreener.com
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Join Class Action Suit Seeking Recovery - Bluefield Daily Telegraph
Actinium Pharmaceuticals Inc (ATNM Stock: A Sea of Opportunity - investchronicle.com
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - GlobeNewswire
Examining Actinium Pharmaceuticals Inc (ATNM) more closely is necessary - uspostnews.com
ROSEN, A LEADING LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider
Levi & Korsinsky Reminds Actinium Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 27, 2025ATNM - marketscreener.com
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
Actinium Pharmaceuticals, Inc. Class Action: Levi & - GlobeNewswire
Actinium Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Actinium Investors of - Bluefield Daily Telegraph
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact The Gross Law Firm - marketscreener.com
0.39%
3.66%
자본화:
|
볼륨(24시간):